TITLE

Does the prophylactic use of N-acetylcysteine prevent contrast nephropathy in patients with renal insufficiency?

AUTHOR(S)
Wai Yan Ma, Irene; Hladunewich, Michelle
PUB. DATE
April 2004
SOURCE
CMAJ: Canadian Medical Association Journal;4/13/2004, Vol. 170 Issue 8, p1231
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses research being done on the implication of the use of N-acetylcysteine to prevent contrast nephropathy in patients with renal insufficiency. Reference to a study by R. Birck, S. Krzossok, F. Markowetz, P. Schnülle and F.J. van der Woude which appeared in a 2003 issue of "Lancet" journal; Range of the baseline serum creatinine in the trials.
ACCESSION #
12695647

 

Related Articles

  • Nephrotoxic Effects in High-Risk Patients Undergoing Angiography. Aspelin, Peter; Aubry, Pierre; Fransson, Sven-Göran; Strasser, Ruth; Willenbrock, Roland; Berg, Knut Joachim // New England Journal of Medicine;2/6/2003, Vol. 348 Issue 6, p491 

    Background: The use of iodinated contrast medium can result in nephropathy. Whether iso-osmolar contrast medium is less nephrotoxic than low-osmolar contrast medium in high-risk patients is uncertain. Methods: We conducted a randomized, double-blind, prospective, multicenter study comparing the...

  • Oral bisphosphonate use in the elderly is not associated with acute kidney injury. Shih, Andrew W Y; Weir, Matthew A; Clemens, Kristin K; Yao, Zhan; Gomes, Tara; Mamdani, Muhammad M; Juurlink, David N; Hird, Amanda; Hodsman, Anthony; Parikh, Chirag R; Wald, Ron; Cadarette, Suzanne M; Garg, Amit X // Kidney International;Oct2012, Vol. 82 Issue 8, p903 

    Intravenous bisphosphonates can cause acute kidney injury; however, this risk was not found with oral bisphosphonates in randomized clinical trials with restrictive eligibility criteria. In order to provide complementary safety data, we studied the risk of acute kidney injury in a...

  • Relationship between dietary protein intake and the changes in creatinine clearance and glomerular cross-sectional area in patients with IgA nephropathy. Wada, Toshikazu; Nakao, Toshiyuki; Matsumoto, Hiroshi; Okada, Tomonari; Nagaoka, Yume; Iwasawa, Hideaki; Gondo, Asako; Niwata, Ami; Kanno, Yoshihiko // Clinical & Experimental Nephrology;Aug2015, Vol. 19 Issue 4, p661 

    Background: Dietary protein intake (PI) induces glomerular hyperfiltration and reduced dietary PI can be effective in preserving kidney function. However, there is limited information regarding the relationship between dietary PI and glomerular histological changes in chronic kidney disease. We...

  • Sodium citrate versus saline catheter locks for non-tunneled hemodialysis central venous catheters in critically ill adults: a randomized controlled trial. Hermite, Laure; Quenot, Jean-Pierre; Nadji, Abdelouaid; Barbar, Saber; Charles, Pierre-Emmanuel; Hamet, Maël; Jacquiot, Nicolas; Ghiringhelli, François; Freysz, Marc // Intensive Care Medicine;Feb2012, Vol. 38 Issue 2, p279 

    Purpose: Sodium citrate has antibacterial and anticoagulant properties that are confined to the catheter when used as a catheter lock. Studies of its use as a catheter lock in chronic hemodialysis patients suggest it may be efficacious in preventing infection and thrombotic complications. We...

  • Plasma exchange for myeloma kidney: cast(s) away? Clark, W. F.; Garg, A. X. // Kidney International;Jun2008, Vol. 73 Issue 11, p1211 

    Leung et al. (this issue) present a retrospective study of 40 patients. Observations in 14/40 led to the suggestion of restitution of plasma exchange for light-chain responsive, biopsy-proven myeloma kidney until a better randomized control trial (RCT) is constructed. A careful analysis of their...

  • Iron dosing in kidney disease: inconsistency of evidence and clinical practice. Gaweda, Adam E.; Ginzburg, Yelena Z.; Chait, Yossi; Germain, Michael J.; Aronoff, George R.; Rachmilewitz, Eliezer // Nephrology Dialysis Transplantation;Feb2015, Vol. 30 Issue 2, p187 

    The management of anemia in patients with chronic kidney disease (CKD) is difficult. The availability of erythropoiesis-stimulating agents (ESAs) has increased treatment options for previously transfusion-requiring patients, but the recent evidence of ESA side effects has prompted the search for...

  • Relationship between Tenofovir-Associated Renal Dysfunction and HAART Regimen. Winslow, Dean L. // Infectious Disease Alert;Mar2008, Vol. 27 Issue 6, p61 

    THIS STUDY FROM THE CALIFORNIA COLLABORATIVE TREATMENT Group examined renal function over time in 146 patients included in the CCTG 578 prospective, randomized clinical trial of therapeutic drug monitoring (TDM). Creatinine clearance (CrCl) was estimated using the Cockcroft-Gault (C-G) equation...

  • A comparison of CKD-EPI estimated glomerular filtration rate and measured creatinine clearance in recently admitted critically ill patients with normal plasma creatinine concentrations. Udy, Andrew A.; Morton, Fraser J.A.; Nguyen-Pham, Sallyanne; Jarrett, Paul; Lassig-Smith, Melissa; Stuart, Janine; Dunlop, Rachel; Starr, Therese; Boots, Robert J.; Lipman, Jeffrey // BMC Nephrology;2013, Vol. 14 Issue 1, p1 

    Background The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) estimated glomerular filtration rate (eGFR) has been widely integrated into clinical practice. Although useful in screening for CKD, its' application in critically ill patients with normal plasma creatinine concentrations...

  • N-Acetylcysteine for the Prevention of Contrast-induced Nephropathy. Liu, Raymond; Nair, Deepu; Ix, Joachim; Moore, Dan H.; Bent, Stephen // JGIM: Journal of General Internal Medicine;Feb2005, Vol. 20 Issue 2, p193 

    Contrast-induced nephropathy is a common cause of acute renal failure in hospitalized patients. Although patients are often given N-acetylcysteine to prevent renal injury from contrast agents, there are no clear guidelines supporting its use. We conducted a systematic review to determine whether...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics